Peptisyntha Overview

  • Founded
  • 1987
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Peptisyntha General Information

Description

Manufacturer of peptidomimetics and peptides for pharmaceutical use. The company's services are used in various stages of preclinical and clinical development and includes peptide synthesis of small quantities, process validation, regulatory support and DMF filing and updates.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Acquirer
International Chemical Investors Group
Primary Office
  • 310 Rue de Ransbeek
  • 1120 Brussels
  • Belgium
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Peptisyntha Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Peptisyntha‘s full profile, request access.

Request a free trial

Peptisyntha Executive Team (3)

Name Title Board Seat Contact Info
Roland Callens Director, Research & Development
You’re viewing 1 of 3 executive team members. Get the full list »

Peptisyntha Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Peptisyntha‘s full profile, request access.

Request a free trial